Provides VWR access to more Merck Millipore products and reagents for chemical and microbiological analysis
April 9, 2014, Billerica, MA — EMD Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany, today announced a new non-exclusive, preferred distribution agreement for Western Europe with VWR a global provider of laboratory supplies, equipment and services. The contract includes a range of EMD Millipore products and reagents for chemical and microbiological analysis, which are mainly used in quality control solutions for the pharmaceutical, food and beverage and chemical industries, as well as products for research in the field of organic synthesis and biosciences.
“The new contract continues an important relationship with one of Merck Millipore’s largest distributors and reinforces our commitment to providing our existing customers easy access to high quality products,” notes Robert Yates, Head of EMD Millipore. “We will give VWR access to more EMD Millipore products and expect with VWR’s wide geographic coverage across Western Europe we will be able to reach a larger customer base.”
The contract replaces an exclusive chemical distribution agreement between Merck Millipore and VWR covering Western Europe originally signed in 2004. Under the new preferred agreement, EMD Millipore is free to engage with other organizations, but VWR will remain the distributor of choice through December 2018.
"VWR is proud to renew its agreement with EMD Millipore, to provide customers with high quality chemical and analysis products,” said Peter Schuele, President European Lab Business, VWR. “We enable science with our assurance of supply through an excellent logistic infrastructure and our ability to combine the chemical offering with consumables, equipment, instrumentation and our rapidly growing service business. EMD Millipore is a very important part in our chemical portfolio and the high value we can bring to our customer base”.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2013 revenues of €2.6 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
About Merck KGaA, Darmstadt, Germany
Merck KGaA of Darmstadt, Germany, is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions EMD Serono, Consumer Health, Performance Materials and EMD Millipore, Merck KGaA generated total revenues of € 11.1 billion in 2013. Around 38,000 Merck KGaA employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck KGaA is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck KGaA, Darmstadt, Germany is holding the global rights to the Merck KGaA name and brand. The only exceptions are Canada and the United States, where the company is known as EMD Millipore.